Page last updated: 2024-08-23

nigericin and Carcinoma, Adenoid Cystic

nigericin has been researched along with Carcinoma, Adenoid Cystic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Andersson, MK; Arteaga Paz, MF; Ghani, LA; Jakobs, A; Klempnauer, KH; Mikesch, JH; Peter von Kries, J; Stenman, G; Trentmann, A; Yusenko, MV	1

Other Studies

1 other study(ies) available for nigericin and Carcinoma, Adenoid Cystic

Article	Year
Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells. Cancer letters, 2020, 06-01, Volume: 479 Topics: Animals; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Monensin; Nigericin; Proteolysis; Proto-Oncogene Proteins c-myb; Pyrans; THP-1 Cells	2020

Article

Year

Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells.

Cancer letters, 2020, 06-01, Volume: 479

Topics: Animals; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Monensin; Nigericin; Proteolysis; Proto-Oncogene Proteins c-myb; Pyrans; THP-1 Cells

2020